Stocks to sell

This year, household goods retailer Bed Bath & Beyond (NASDAQ:BBBY) faces substantial financial problems, and BBBY stock investors are deep underwater. Granted, the company hasn’t officially declared a Chapter 11 filing. However, it’s probably only a matter of time before Bed Bath & Beyond spirals into bankruptcy. So, if you’re a current shareholder, consider hitting the

As much as I love dividend stocks, it’s important to note that I don’t love all dividend stocks; and you shouldn’t either. There are certainly some dividend stocks to avoid out there. Dividends are great. They are quarterly (or sometimes monthly) payouts to investors as a reward for holding a stock. Retirement investors love dividends

While SoFi (NASDAQ:SOFI) is growing rapidly and should benefit significantly from the likely end of the student-loan payment moratorium in August, the company has important weaknesses and is facing threats that could potentially be very debilitating. Its weaknesses are its lack of profitability and the high interest rate that it’s paying on its deposits. Among

Investing would be a lot easier if you didn’t have to worry about underperforming stocks to get rid of. Wouldn’t it be great if stocks did what you thought they would do when you bought them? But that’s part of the game you play when you invest in the stock market. We can use tools, metrics

After spiking following GameStop’s (NYSE:GME) latest quarterly earnings release on March 21, GME stock has held steady in the low-$20s per share. Managing not to cough back its most recent gains just yet, some may believe that shares in the video game retailer have the potential to rise further from here. But while another “meme

These are the worst EV stocks to own as the market reshuffles. The competition in the electric vehicle battleground has been heating up nicely, leaving many contenders in the dust. As established automotive giants such as Ford and others charge ahead with their respective EV lineups, the market seems to be drawing a line to

As our trusty authors have covered in detail, electric vehicle (EV) manufacturer Mullen Automotive (NASDAQ:MULN) just received what looks like a $110 million bailout. However, it’s an awfully flimsy lifeline for an automaker that’s in deep financial trouble. If you’re waiting around for MULN stock to recover, don’t hold your breath. It’s entirely possible that

There are plenty of risky dividend-paying stocks with company-specific issues that make them clearly dividend stocks to avoid, but there are also some names in this category where the reason to stay away is not so apparent. One such example is with shares in companies facing possible regulatory scrutiny. This regulatory scrutiny may threaten future

Plenty of traders are still willing to risk their hard-earned capital on electric vehicle (EV) manufacturer Lucid Group (NASDAQ:LCID). I wish I could offer them some comfort and a positive outlook. However, LCID stock investors need to prepare for a crash landing. Lucid Group’s recently released results only add to the bearish thesis, unfortunately. Lucid Group’s

There are winners and losers in every type of market. While the share prices of some companies soar, others plunge. This can be due to a number of factors, ranging from earnings misses and weak forward guidance to fraud, mismanagement, bankruptcy and public criticism. Whatever the reason, there are many stocks that investors should avoid

The markets may be showing solid signs of improvement, but there are still many stocks to sell. In fact, in this environment of elevated interest rates, stocks with unrealistically high valuations are likely to come back to earth sooner rather than later. So, here are seven stocks to sell in April that are very likely to

Finding the best pharma stocks to sell can be an all-or-nothing kind of business. If you score on a company making a breakthrough in a new drug or treatment, the rewards can be extreme, but investing in pharma stocks can also mean heavy expenditures on research and testing for a drug that may not perform

If Novavax (NASDAQ:NVAX) stock investors are looking for a shot in the arm, they’re going to be disappointed. Even Novavax’s management expressed doubts regarding the company’s ability to continue long term. Like it or not, the evidence overwhelmingly suggests that it’s not a wise move to take a share position in Novavax. Let’s face it. Covid-19

After a wretched 2022, tech stocks are rebounding nicely this year. The tech-heavy Nasdaq composite is up nearly 14% since Jan. 1, better than the Dow Jones Industrial Average and the S&P 500. And we’re nowhere near the top of this run higher. If you consider the Nasdaq composite a rough indicator of tech stocks,

Among cannabis stocks, SNDL (NASDAQ:SNDL) has been one that screens well as a value play. Even though this Canada-based integrated cannabis company isn’t cheap on a price-to-earnings basis, SNDL stock has for quite some time traded at a discount to its tangible book value. But investors who have bought it based on its low valuation

There’s a long-term shift in the automotive industry toward electric vehicles. However, not all players in the industry will be winners. In fact, there are quite a few EV stocks to sell, as the industry is full of companies that came public over the past few years with little track record of success or commercial

It’s fine to seek out low-priced tech stocks, but I definitely do not recommend Exela Technologies (NASDAQ:XELA) stock. Exela Technologies has financial problems and the company’s shares are at risk of being delisted from the Nasdaq exchange. So, there’s too much risk to justify an investment in Exela Technologies. Headquartered in Texas, Exela Technologies specializes in business

Mullen Automotive (NASDAQ:MULN) stock is once again making headlines, but these latest developments aren’t being met with much excitement based on recent price action. In the past few weeks, this early-stage electric vehicle manufacturer has hit a major milestone. The company has closed on a large financing deal. Shares have barely budged on this news.

So, it’s settled: Canadian cannabis producer Tilray (NASDAQ:TLRY) plans to acquire rival Hexo (NASDAQ:HEXO). It’s debatable, however, whether this is actually a good idea. In the same press release, Tilray disclosed its financial results for the third quarter of fiscal 2023. Suffice it to say, the data doesn’t look promising, and it’s not a good

This hasn’t been a good year for EV stocks.  While the future is certainly electric, EV makers have had a difficult time dealing with the China lockdown and supply chain issues. The EV bubble may not burst anytime soon but a lot of companies could end up losing money.  Many EV stocks have taken a